Autonomic Neural Blockade in Bariatric Surgery
Recruiting
N/A
Interventional Study
Bariatric Surgery Candidate
Pain, Postoperative
Nausea and Vomiting, Postoperative
Opioid Use
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Endeavor Health · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this research is to evaluate if autonomic nerve block (ANB- blocking pain and nausea signals) decreases pain and anti-nausea medication requirements as well as the experience of pain/nausea during the first 72 hours after sleeve gastrectomy or gastric bypass surgery. Participants will be randomly assigned either to the standard of care or the ANB group before surgery. As part of sta…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals able and willing to consent and participate in all study activities
* Adults, ages 18-90
* All patients with severe obesity undergoing laparoscopic/robotic gastric bypass or sleeve gastrectomy
Exclusion Criteria:
* Patients taking opiates chronically
* Patients a…
Contacts